public Contact Us

Products

Products Himlaca®

Himlaca®

Products 01

Himalca®Scientifically proven Centella Asiatica extract for Eye, Liver, and Cognitive health

Functional Health Claim

  • Support eye health by maintaining the density of macular pigments which can be affected by aging
  • Support liver health by preventing non-alcoholic liver injury
  • Support cognitive health by preventing cognitive decline and memory impairment

Dosage

  • 300mg/day as Centella Asiatica extract

Active Compound

Name Asiaticoside
Molecular Formula C48H78O19
Molecular Weight 959.1
CAS No. 16830-15-2
Asiaticoside

Clinical Trial

1Eye Health

  • Subject80 elderly male or female participants aged 45-65 years, with low MPOD levels (0.2 to 0.4)
  • MethodTake Himalca®(Centella Asiatica extract) 300 mg/day for 180 days
    A double-blind, randomized, and placebo-controlled study

MPOD improvement beginning after 60 days (visit 2)

Eye Health 1

MPOD was significantly improved after 180 days
compared to the control group (P < 0.01)

Eye Health 2

Nutrients 2026, 18, 905

2Liver Health

  • Subject80 elderly male or female participants aged 20-70 years, with ALT level 45 ~ 135 U/L and AST level 25 U/L or higher in the previous 2 weeks
  • MethodTake Himalca®(Centella Asiatica extract) 300 mg/day for 180 days
    A Randomized, Double-Blind, Placebo-Controlled Parallel study
  • Before (Placebo)
  • After (Placebo)
  • Before (Himalca®)
  • After (Himalca®)

ALT decreased 36.7%
AST decreased 27%
GGT decreased 18.8%

Liver Health 1

Lipid metabolism-related markers
TG and TC significantly decreased

Liver Health 2

Appl. Sci. 2021, 11, 11498.

3Cognitive health

  • - TBU -

Patents

Patent name Registration status
Composition for preventing or treating retinal disease comprising compounds isolated from Centella asiatica extract KP Registered
  • KP10-2284682

    KP10-2284682
    (2021.07.27)

Patent name Registration status
Composition for preventing or treating retinal disease, containing Centella asatica extract KP, EP, JP Registered
PCT, US, CN Pending
  • KP10 -2181864

    KP10 -2181864
    (2020.11.17)

  • EP3868218

    EP3868218
    (2023.05.07)

  • JP07648529

    JP07648529
    (2025.03.10)

For more details